Upfront Combination Pulmonary Arterial Hypertension Therapy
NCT03809156
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Hypertension
Interventions
DRUG:
Riociguat Oral Product
Sponsor
University of Calgary
Collaborators
[object Object]